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This communication states the changing patterns of Salmonella enterica serovar Typhi (S. Typhi) isolates causing enteric fever
in and around Kolkata, India. Among the isolates resistance to ampicillin (A), chloramphenicol (C), cotrimoxazole (Co) and
tetracycline (T) were plasmid mediated; the plasmid was unstable in S. Typhi, and the other enteric bacteria like Escherichia coli,
Klebsiella pneumoniae and Proteus vulgaris were found to be the potential source of dissemination of such plasmids into S. Typhi.
The infection with such S. Typhi strains were successfully treated with ciproﬂoxacin (Cp: MICs 0.0075–0.075μgmL −1) and/or
oﬂoxacin (Ofx: MICs 0.0125–0.075μgmL −1), but in the later course, the S. Typhi strains, showing resistance to nalidixic acid,
developed low level of resistance to Cp and Ofx, causing the treatment failure. Thus, the treatment regimen was shifted to the
third generation cephalosporins like ceftriaxone (Ct) and cefotaxime (Cf). Keeping in mind the anticipation of development of
resistance to Ct/Cf, we prepared the treatment regimen for MDR enteric fever, based on the double-drug synergy tests in vitro;
Cp-gentamycin (FICI 0.121–0.216) and Cp-trimethoprim (FICI 0.14–0.483) combinations were found eﬀective against S. Typhi
isolates having decreased sensitivity to cp (MICs: 0.5–1.25μgmL −1).
1.Introduction
Typhoid fever, the causative agent of which is Salmonella
enterica serovar Typhi (S. Typhi), remains a serious public
health problem in many developing countries, with highest
incidence in parts of Africa (50 per 100.000 person-years)
and Asia (274 per 100.000 person-years) [1, 2]. The period
1990 to the present has been a hallmark era in the history of
enteric fever because of the emergence and dissemination of
S. Typhi strains carrying resistance to multiple clinically rele-
vant antibiotics [3, 4]. In India enteric fever is a major public
health problem accounting for more than 300,000 cases
per year and S. Typhi is the commonest etiological agent.
Most developing countries have experienced outbreaks of
multidrug-resistant (MDR) enteric fever due to S. Typhi;
Kolkata (Calcutta) and its suburbs also faced epidemic of
enteric fever caused by life threatening infection of S.T y p h i
[5].
The above background prompted us to (i) determine the
antibiotic resistance pattern of outbreak causing as well as
sporadic isolates of S. Typhi (1991–2001) obtained at the
Calcutta School of Tropical Medicine from blood cultures
fromentericfeverpatients withinandoutsideKolkata,India,
(ii) determine the dissemination of R-factor of S.T y p h i
isolates, (iii) correlate the zone diameter of inhibition (ZDI)
and minimum inhibitory concentration (MIC) values for
evaluation of resistance to ciproﬂoxacin (Cp) and to evaluate
the Nalidixic acid (Nx) resistance as a marker for decreased2 The Scientiﬁc World Journal
Cp susceptibility in S. Typhi isolates, and (iv) evaluate the in
vitro eﬃcacy of various combination of antibiotics against S.
Typhi in order to combat antibiotic resistance.
2. The Study
The S. Typhi isolates showed ﬂip-ﬂop patterns of resistance
to ampicillin (A), chloramphenicol (C), co-trimoxazole
(Co), and tetracycline (T) with wide range of MICs, 0.1–
6000,0.1–5000, 0.5–1200,and0.5–800μgmL −1,r especti v ely .
A total of 421 S. Typhi isolates from blood samples of
suspected enteric fever patients undergoing treatment at the
Calcutta School of Tropical Medicine, Kolkata (India), were
used in the present study; a single strain was isolated from
a each of the cases. The control strain used in the study was
Escherichia coli ATCC 25922.
The presence of R-factor in S. Typhi (resistance pattern
ACCoT or ACCoTNx) was established by (a) transfer of
resistance from MDR S. Typhi to the Escherichia coli C600
recipients (NxR,F −)b yin vitro conjugation experiments, (b)
secondary transfer of R-factor to the antibiotic-sensitive S.
Typhi isolates, (c) elimination of antibiotic resistance from
donorsaswellastransconjugantsbycuringexperiments,and
(d) isolation of plasmid DNAs from the donors, recipients,
transconjugants, and cured strains. A conjugative plasmid
of approximately 55kb was associated in mediating ACCoT
resistance among the MDR S. Typhi isolates, while the anti-
biotic sensitive isolates were plasmidless.
On the other hand, the antibiotic-sensitive S. Typhi
strains acquired ACCoT resistance along with the acqui-
sition of a plasmid (comigrated with the MDR S. Typhi
plasmid) from clinical isolates of MDR Escherichia coli
(resistance pattern ACCoTNx or ACCoTNxCp), Klebsiella
pneumoniae(resistancepatternACCoT),andProteusvulgaris
(resistance pattern ACCoT). Resistance to Nx and Cp was
not transferable. After curing experiments, the loss of
ACCoT resistance from the original MDR S. Typhi strains,
all types of transconjugant S. Typhi strains and MDR E. coli
strains were concomitant with the loss of the plasmid.
The MDR enteric fever cases were treated successfully
with Cp (500mg) or Ofx (200mg) twice daily for 5 days.
The associated S. Typhi isolates showed MICs 0.0075–
0.075μgmL −1 for Cp and 0.0125–0.075μgmL −1 for oﬂox-
acin (Ofx). The S. Typhi isolates (1995 onwards) showing
Cp MICs 0.1–1.25μgmL −1 and equivalent ZDI of ≥21mm
caused treatment failure during Cp therapy. We encountered
problem in treating enteric fever with Ofx (200mg twice
daily for 5 days) too during and after 1996, although the
isolates fall within the sensitive range by disc diﬀusion
method (≥16mm). The corresponding isolates showed high
MICs of Ofx (0.5–1.5μgmL −1) .I no r d e rt od e t e r m i n et h e
MICs of antibiotics and ZDIs around the antibiotic discs, the
methods of the Clinical and Laboratory Standards Institute
(CLSI, formerly called the National Committee for Clinical
Laboratory Standards; NCCLS) were followed [6, 7].
The relevance of using the resistance to Nx as a marker
for Cp resistance in S. Typhi isolates was evaluated by
comparing the MICs of Cp and that of Nx (Figure 1),
and MICs of Cp and ZDI obtained around 30μgN x
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Figure 1: Scattergram for 421 S. Typhi isolates correlating the
minimum inhibitory concentration (MIC) values of nalidixic acid
(Nx)totheMICsofciproﬂoxacin(Cp).Thebrokenhorizontallines
represent the NCCLS breakpoint recommendations for suscepti-
bility (MIC, ≤16μg/mL) and resistance (MIC, ≥32μg/mL) to Nx.
The numbers within the graphic indicate the number of S. Typhi
isolates.
disc (Figure 2). When Cp MIC of ≥0.1μgmL −1 was used
as a breakpoint of decreased Cp susceptibility (signifying
resistance), the sensitivity of Nx disc was 100%, and the
speciﬁcitywas89.20%,andwhenMICsofNxwerecompared
with that of Cp, sensitivity of the approach was 100% and
speciﬁcity was 95.95%. The applicability of Nx resistance to
screen for decreased susceptibility (low level of resistance) to
Ofx and norﬂoxacin (Nfx) among the S. Typhi isolates was
also explored in our study and the method emerged useful
and signiﬁcant.
In order to prepare a universally observed guideline for
the worldwide surveillance of the emergence and spread
of ﬂuoroquinolone-resistant S. Typhi isolates, we assessed
the applicability of ﬂuoroquinolone disc diﬀusion test by
scattergram analysis between ﬂuoroquinolone MICs and
ZDIobtainedaround5μgﬂuoroquinolonedisc.Considering
Cp MIC of ≥0.1μgmL −1 as the breakpoint for Cp resistance,
Cp ZDI of ≤29mm resulted in 100% sensitivity and 36.15%
speciﬁcity in detecting Cp resistance for S. Typhi isolates.
Similarly, when Ofx MIC of ≥0.5μg/mL was used as a
breakpoint for Ofx resistance, Ofx ZDI of ≤29mm results
in 100% sensitivity and 51.2% speciﬁcity in screening for
Ofx resistance among the isolates. In case of Nfx, when MIC
of ≥0.1μg/mL was taken as the breakpoint, Nfx ZDI of
≤23mm produced 100% sensitivity and 49.22% speciﬁcity
in detecting reduced Nfx susceptibility among S. Typhi
isolates.
The therapeutic eﬃcacy of ceftriaxone (Ct) against the
enteric fever patients infected with Cp-resistant S.T y p h i
had been checked by susceptibility testing with Ct for the
isolates; the in vitro eﬃcacy of cefotaxime (Cf) was also
assessed. We observed a correlation between the results of
disc diﬀusion and agar dilution testing for susceptibility
to Ct and Cf by scattergram analysis between MICs and
ZDI. For the isolates, the MICs of Ct and Cf were 0.005–
0.2μgmL −1 and 0.005–0.1μgmL −1, respectively, and ZDIs
obtained around 30μgC ta n d3 0μg Cf discs were 26–41mmThe Scientiﬁc World Journal 3
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Figure 2: Scattergram plotting the minimum inhibitory concentra-
tion (MIC) values of ciproﬂoxacin (Cp) and zone diameter of inhi-
bition (ZDI) around 30μg nalidixic acid (Nx) disc for 421 S. Typhi
isolates processed by the NCCLS methods. The broken vertical
lines represent interpretative ZDI suggested for Enterobacteriaceae
(susceptible at ≥19mm, resistant at ≤13mm). The numbers within
the graphic indicate the number of S. Typhi isolates.
and 24–42mm, respectively. The isolates showed excellent in
vitro susceptibility to aminoglycosides (Amikacin; Ak, and
gentamicin; G).
The acquisition and spread of multidrug resistance
among S. Typhi isolates constitute a major threat in mod-
ern medicine. Therefore, in order to prepare cost-eﬀective
treatment regimen of enteric fever due to the infection of
Cp-resistant S. Typhi, combination eﬀect of Cp with various
other antibiotics has been evaluated in the present study by
(a) agar dilution checker board, (b) double disk synergy,
and (c) time kill methods. The current ﬁndings represent
the ﬁrst time that an antimicrobial, here Cp, has its activity
signiﬁcantly increased with Ax. This view is supported by
very low fractional inhibitory concentration (FIC) values of
Cp (0.004–0.256μgmL −1) in combination with amoxicillin
(Ax). The Cp-trimethoprim (TMP) combination exhibited
synergistic eﬀect for all the isolates tested (FIC indices 0.140–
0.483). The interaction between Cp and G was found to be
synergisticagainstS.Typhi,since,inthisstudy,thecalculated
FIC indices ranged from 0.121 to 0.216. The Cp-cefazolin
(Cz) combination resulted in both synergistic (for isolates
with high Cz MICs) and additive (for isolates with low
Cz MICs) eﬀects. Synergy was deﬁned as the FIC index
≤0.5, addition as an FIC index 0.5–4, and antagonism as
an FIC index >4[ 8], and the overall interaction of Cp in
combination with other four antibiotics are represented in
Table 1.
3. Conclusion
In Kolkata (India), enteric fever due to the infection of S.
Typhi A is endemic. A conjugative plasmid (approximately
of 55kb) was involved mediating resistance to A, C, Co,
and T in outbreak causing as well sporadic MDR isolates of
S. Typhi, while antibiotic-sensitive isolates were plasmidless.
Previous report indicated plasmids of molecular weight 25.4
Table 1: Interaction of Cp (ciproﬂoxacin) in combination with G
(gentamicin), trimethoprim (TMP), amoxicillin (Ax) and cefazolin
(Cz) against S. enterica serovar Typhi isolates.
Antibiotic
combination MIC (μg/mL) FIC (μg/mL) FIC index
Cp-G Cp: 0.75–1.25 Cp: 0.008–0.032 0.121–0.216
GM: 0.75–2 GM: 0.1–0.2
Cp-TMP Cp: 0.5–1 Cp: 0.025–0.125 0.14–0.483
Tm: 10–125 Tm: 5–10
Cp-Ax Cp: 1–1.25 Cp: 0.004–0.256 0.504–0.832
Ax: 0.5–16 Ax: 0.25–10
Cp-Cz Cp: 0.5–1.25 Cp: 0.075–0.25 0.35–0.916
Cz: 2.5–60 Cz: 1.25–2.5
FIC: fractional inhibitory concentration; MIC: minimum inhibitory con-
centration.
and 62.5kb to be more frequent among strains with the
resistance pattern ACoCT [9]. In S. Typhi, the R plasmid is
anunstableplasmidthatmayappearordisappearatanytime
resultingintheemergenceofdrug-resistantordrug-sensitive
isolates, and its acquisition (from other enteric bacteria like
E. coli, P. vulgaris, K. pneumoniae) is mainly due to antibiotic
load exposed to them during therapy.
Cp should be the antibiotic of choice for MDR typhoid
fever. Longer course of Ofx therapy might be instituted in
the treatment of MDR cases showing nonresponsiveness to
Cp. Present ﬁnding underlines the importance of Ct for
treating MDR and Cp-resistant enteric fever cases, and it
should be used only if the ﬁrst- and second-line antibiotics
fail to evoke a satisfactory response or if the isolate is
resistanttoNx.However,theCtresistanceisanticipated[10].
Emergence of ﬂuoroquinolone-resistant S. Typhi isolates
showing sensitivity to C, A, and Co provides a strong case
for reconsidering the use of the ﬁrst line of antibiotics for
treatment of enteric fever in this region. Another study
from Kolkata has indicated similar sensitivities (85.6% for A,
83.6% for C, 83.1% for Co) [11].
Either the MIC breakpoints or the equivalent ZDI
suggested by the NCCLS did not detect ﬂuoroquinolone
resistance of S.T y p h i . Nx susceptibility has been validated
as a screening test for reduced susceptibility to Cp, and Nx-
resistance is associated with a high MIC of Cp, which in
turn is associated with treatment failure; earlier authors also
reported similar phenomenon [12]. The reference laborato-
ries should assess the applicability of the disc diﬀusion test
with ﬂuoroquinolones in detecting decreased susceptibility
to these drugs by scattergram analysis. In enteric fever
combined antibiotic therapy may be introduced in order to
combat multidrug resistance of S. Typhi and also to prevent
emergence of resistance to ﬂuoroquinolones and newer
antibiotics such as third-generation cephalosporins. Thus,
physicians should be aware about the overuse and misuse
of ﬂuaroquinolones and cephalosporins in the treatment of
typhoid fever to overcome the burden of drug resistance, and
with Ct emerging as the sole defense against Nx-resistant S.
Typhi infection, it should be instituted only in the event of4 The Scientiﬁc World Journal
nonresponsiveness to Cp [3]. The data generated from the
entirestudyisthusexpectedtobehelpfulintheintroduction
of new way of evaluation of drug resistance of S. Typhi and
treatment protocol, beneﬁting a large number of people of
this region of the world, where enteric fever is a major public
health problem.
References
[1] A.Kothari,A.Pruthi,andT.D.Chugh,“Theburdenofenteric
fever,” Journal of Infection in Developing Countries, vol. 2, no.
4, pp. 253–259, 2008.
[2] J .A.C rump ,S.P .L ub y ,andE.D .Mintz,“Theglobalbur denof
typhoid fever,” Bulletin of the World Health Organization, vol.
82, no. 5, pp. 346–353, 2004.
[3] D.Arora,R.Singh,M.Kaur,andR.S.Ahi,“Achangingpattern
in antimicrobial susceptibility of Salmonella enterica serotype
isolated in North India,” African Journal of Microbiology
Research, vol. 4, no. 3, pp. 197–203, 2010.
[4] M. R. Saha, P. Dutta, S. K. Bhattacharya et al., “Occurrence
of multi-drug resistant Salmonella typhi in Calcutta,” Indian
Journal of Medical Research A, vol. 95, pp. 179–180, 1992.
[ 5 ]R .K .A r o r a ,A .G u p t a ,N .M .J o s h i ,V .K .K a t a r i a ,P .L a l l ,a n d
A. C. Anand, “Multidrug resistant typhoid fever: study of an
outbreak in Calcutta,” Indian Pediatrics, vol. 29, no. 1, pp. 61–
66, 1992.
[6] National Committee for Clinical Laboratory Standards, Per-
formance Standards for Antimicrobial Disc Susceptibility Tests.
Approved Standards M2-A6, National Committee for Clinical
Laboratory Standards, Wayne Pa, USA, 7th edition, 2000.
[7] Clinical and Laboratory Standards Institute, “Performance
Standards for Antimicrobial Susceptibility testings. Fifteenth
informational supplement,” CLSI Document M100-S15, Clin-
ical and Laboratory Standards Institute, Wayne, Pa, USA,
2005.
[8] R. Leclercq, E. Bingen, Q. H. Su, N. Lambert-Zechovski,
P. Courvalin, and J. Duval, “Eﬀects of combinations of β-
lactams, daptomycin, gentamycin and glycopeptides against
glycopeptide resistant Enterococci,” Antimicrobial Agents and
Chemotherapy, vol. 35, no. 1, pp. 92–98, 1991.
[9] J. H. Tran and G. A. Jacoby, “Mechanism of plasmid-mediated
quinolone resistance,” Proceedings of the National Academy of
SciencesoftheUnitedStatesofAmerica,vol.99,no.8,pp.5638–
5642, 2002.
[10] M. A. Mushtaq, “What after ciproﬂoxacin and ceftriaxone in
treatment of Salmonella typhi,” Pakistan Journal of Medical
Sciences, vol. 22, no. 1, pp. 51–54, 2006.
[11] B. Sen, S. Dutta, D. Sur et al., “Phage typing, biotyping and
antimicrobialresistanceproﬁleofSalmonellaentericaserotype
Typhi from Kolkata,” Indian Journal of Medical Research, vol.
125, no. 5, pp. 685–688, 2007.
[12] A.Kapil,Renuka,andB.Das,“Nalidixicacidsusceptibilitytest
to screen ciproﬂoxacin resistance in Salmonella typhi,” Indian
Journal of Medical Research, vol. 115, pp. 49–54, 2002.